Covid-19 roundup: FDA and NIH leaders continue sharing lessons from the pandemic; Slovenia halts J&J vaccine rollout to investigate death — report

Nicole DeFeudis

Editor

Paul Schloesser

Associate Editor

Back in March, FDA acting commissioner Janet Woodcock and NIH director Francis Collins began the long, slow process of explaining some of the lessons they’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: FDA and NIH leaders continue sharing lessons from the pandemic; Slovenia halts J&J vaccine rollout to investigate death — report

Nicole DeFeudis

Editor

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: FDA and NIH lead­ers con­tin­ue shar­ing lessons from the pan­dem­ic; Slove­nia halts J&J vac­cine roll­out to in­ves­ti­gate death — re­port

Editor

Associate Editor

Sign up to read this article for free.

Covid-19 roundup: FDA and NIH leaders continue sharing lessons from the pandemic; Slovenia halts J&J vaccine rollout to investigate death — report